4//SEC Filing
White Mark Andrew 4
Accession 0001140361-24-045101
CIK 0001281895other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 4:06 PM ET
Size
4.9 KB
Accession
0001140361-24-045101
Insider Transaction Report
Form 4
White Mark Andrew
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-10-31$16.63/sh−3,080$51,205→ 69,140 total
Footnotes (2)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F2]The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001973240
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 4:06 PM ET
- Size
- 4.9 KB